[
  {
    "ts": null,
    "headline": "Bristol Myers Squibb Co. stock rises Tuesday, still underperforms market",
    "summary": "Bristol Myers Squibb Co. stock rises Tuesday, still underperforms market",
    "url": "https://finnhub.io/api/news?id=62e291d58354ef42c69c4cf9cbe4ed9d7eca0a4d59968db781f292093773d900",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1735058460,
      "headline": "Bristol Myers Squibb Co. stock rises Tuesday, still underperforms market",
      "id": 132148491,
      "image": "",
      "related": "BMY",
      "source": "MarketWatch",
      "summary": "Bristol Myers Squibb Co. stock rises Tuesday, still underperforms market",
      "url": "https://finnhub.io/api/news?id=62e291d58354ef42c69c4cf9cbe4ed9d7eca0a4d59968db781f292093773d900"
    }
  },
  {
    "ts": null,
    "headline": "BMY Gets EC Nod for Opdivo Plus Yervoy in First-Line Colorectal Cancer",
    "summary": "The European Commission approves Bristol Myers' Opdivo plus Yervoy for first-line treatment of MSI-H or dMMR unresectable or metastatic colorectal cancer.",
    "url": "https://finnhub.io/api/news?id=b218874f5e9faabb427dc8b4eeaad0f023d202c17bebf6fffd787d8f01bc7c8c",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1735056360,
      "headline": "BMY Gets EC Nod for Opdivo Plus Yervoy in First-Line Colorectal Cancer",
      "id": 132136342,
      "image": "",
      "related": "BMY",
      "source": "Yahoo",
      "summary": "The European Commission approves Bristol Myers' Opdivo plus Yervoy for first-line treatment of MSI-H or dMMR unresectable or metastatic colorectal cancer.",
      "url": "https://finnhub.io/api/news?id=b218874f5e9faabb427dc8b4eeaad0f023d202c17bebf6fffd787d8f01bc7c8c"
    }
  },
  {
    "ts": null,
    "headline": "Bristol Myers Squibb Receives European Commission Approval for Opdivo plus Yervoy for the First-Line Treatment of Adult Patients with Microsatellite Instability-High or Mismatch Repair Deficient Metastatic Colorectal Cancer",
    "summary": "PRINCETON - Bristol Myers Squibb today announced that the European Commission has approved Opdivo plus Yervoy for the first-line treatment of adult patients with microsatellite instability-high ...",
    "url": "https://finnhub.io/api/news?id=f9e246f76e842104fa1308910893865c639d44109c25ae09ff2e283fe6240af0",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1735033843,
      "headline": "Bristol Myers Squibb Receives European Commission Approval for Opdivo plus Yervoy for the First-Line Treatment of Adult Patients with Microsatellite Instability-High or Mismatch Repair Deficient Metastatic Colorectal Cancer",
      "id": 132131896,
      "image": "",
      "related": "BMY",
      "source": "Finnhub",
      "summary": "PRINCETON - Bristol Myers Squibb today announced that the European Commission has approved Opdivo plus Yervoy for the first-line treatment of adult patients with microsatellite instability-high ...",
      "url": "https://finnhub.io/api/news?id=f9e246f76e842104fa1308910893865c639d44109c25ae09ff2e283fe6240af0"
    }
  },
  {
    "ts": null,
    "headline": "Bristol Myers Squibb Announces Positive Topline Results from Two Pivotal Phase 3 Trials Evaluating Sotyktu in Adults with Psoriatic Arthritis",
    "summary": "PRINCETON - Bristol Myers Squibb today announced results from POETYK PsA-1 and POETYK PsA-2 , the pivotal Phase 3 trials evaluating the efficacy and safety of Sotyktu in adults with active...",
    "url": "https://finnhub.io/api/news?id=216aafe38d141aa9cce0f39c2cde05665ed1601e3238fb31e4de750911448bb7",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1735033751,
      "headline": "Bristol Myers Squibb Announces Positive Topline Results from Two Pivotal Phase 3 Trials Evaluating Sotyktu in Adults with Psoriatic Arthritis",
      "id": 132131875,
      "image": "",
      "related": "BMY",
      "source": "Finnhub",
      "summary": "PRINCETON - Bristol Myers Squibb today announced results from POETYK PsA-1 and POETYK PsA-2 , the pivotal Phase 3 trials evaluating the efficacy and safety of Sotyktu in adults with active...",
      "url": "https://finnhub.io/api/news?id=216aafe38d141aa9cce0f39c2cde05665ed1601e3238fb31e4de750911448bb7"
    }
  }
]